Tempol improves neuroinflammation and delays motor dysfunction in a mouse model (SOD1G93A) of ALS.

Altogether, our results indicate that treatment with tempol has beneficial effects, delaying the onset of the disease by enhancing neuronal survival and decreasing glial cell reactivity during ALS progression in SOD1G93A mice.